Immunomodulators and delivery systems for vaccination by mucosal routes-Reference-Cited by-同舟云学术

Immunomodulators and delivery systems for vaccination by mucosal routes

Published:2001-08 Issue:8 Volume:19 Page:293-304
ISSN:0167-7799
Container-title:Trends in Biotechnology
language:en
Short-container-title:Trends in Biotechnology

Author:

Ryan Elizabeth J,Daly Lyn M,Mills Kingston H.G

Publisher

Elsevier BV

Subject

Bioengineering,Biotechnology

Reference105 articles.

1. Genetic immunization is a simple method for eliciting an immune response;Tang;Nature,1992

2. Total and IgE antibody levels following booster immunization with aluminum absorbed and non-absorbed tetanus toxoid in humans;Cogne;Ann. Allergy,1985

3. Induction of HIV-specific CD8+ CTL and CD4+ Th1 cells by immunization with recombinant gp120 entrapped in biodegradable microparticles;Moore;Vaccine,1995

4. Innate immunity: the virtues of a nonclonal system of recognition;Medzhitov;Cell,1997

5. Vaccines for mucosal immunity to combat emerging infectious diseases;Van Ginkel;Emerg. Infect. Dis.,2000

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based pulmonary particulate systems for anticancer and antiviral drug carriers: A promising delivery for COVID-19 vaccines;Results in Chemistry;2023-12

2. Current Approaches to Antimicrobial Formulations and their Delivery;Current Trends in the Identification and Development of Antimicrobial Agents;2023-03-07

3. Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges;Immunity, Inflammation and Disease;2022-03-10

4. Emerging trends in vaccine delivery systems;System Vaccinology;2022

5. A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID‐19;Journal of Applied Microbiology;2021-07-26